Ukko

Safer Proteins for People with Food Allergies and Sensitivities

Agriculture & Food Technologies
Active
Series A Rehovot Founded 2016
Total raised
$47.7M
Last: Series A 2025-06
Stage
Series A
Founded
2016
Headcount
51
HQ
Rehovot
Sector
Agriculture & Food Technologies

About

Ukko's mission is to improve the lives of people with food allergies and sensitivities. Ukko uses immunology, machine learning, and protein engineering to make measurably better and safer proteins for use in food and therapeutics. Ukko does this by designing and controlling the molecular interactions between allergen proteins and the immune system. Ukko's technology uses samples from patients and machine learning to guide the engineering of superior proteins that can be incorporated into food products and therapeutics. These proteins maintain or improve beneficial properties (taste, nutritional value, yield, and physicochemical and mechanical properties) but do not trigger an immune response. Ukko's initial product pipeline includes celiac-safe gluten proteins, allergy-safe and therapeutic peanut proteins, as well as a pipeline of additional allergen proteins.

Funding history · 3 rounds · $47.7M total

2025-06
Series A Undisclosed
2021-01
Series B $40.0M
2017-07
Series A $7.7M

Sectors & technology

Primary sector
Agriculture & Food Technologies
Sub-sectors
Agriculture & Food TechnologiesFood TechNovel Food & Ingredients
Technologies
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsAgriculture & FoodProcessed FoodsIngredients
Business model
B2B

Highlights

Verified

Tags

biotechnologyfoodtechfood-ingredientsmolecular-biologyconsumersbig-datapharmaceuticalstherapeuticsimmunologyallergyproteinsartificial-intelligence